About MSPharma
MSPharma is a Healthcare company based in Amman (Jordan) founded in 1989. Generic formulations are manufactured by MSPharma across multiple therapeutic categories. MSPharma has raised $45 million across 2 funding rounds from investors including International Finance Corporation and EBRD. MSPharma has completed 1 acquisition, including Genepharm. Its website mspharma.com draws about 12 thousand monthly visits. MSPharma offers products and services including Generic Medicines, Specialty Medicines, and Biotech Products. Its focus areas include Diversified Pharmaceuticals.
Company details
MSPharma was founded in 1989 in Amman, Jordan, within the pharmaceutical sector. Generic formulations are produced for therapeutic areas such as cardiovascular, central nervous system, respiratory, infections, endocrine, obstetrics, gynecology, urinary tract, and musculoskeletal conditions. Over-the-counter products are also manufactured, including gastrointestinal treatments, medico-cosmetics, feminine healthcare, baby care, cold and cough remedies, pain relief, diagnostics, food supplements, nutraceuticals, and multivitamins. Operations focus on standard pharmaceutical manufacturing processes.
- Total Equity Funding$45M (USD)
in 2 rounds
- Latest Funding Round$45M (USD), Private Equity Round
May 2017
- InvestorsInternational Finance Corporation
& 1 more
- Investments & Acquisitions
Products & Services of MSPharma
MSPharma offers a comprehensive portfolio of products and services, including Generic Medicines, Specialty Medicines, and Biotech Products.
Cost-effective equivalents of branded drugs for various treatments
Advanced therapies for specific diseases and conditions
Innovative biological medicines targeting oncology and other areas
Apps and channels of MSPharma
its YouTube channel MS Pharma has 185 subscribers and 30 videos.
Videos from MSPharma
The most watched videos on MSPharma's YouTube channel, MS Pharma (185 subscribers). Click a video to play it here.
More on MS Pharma.
Funding Insights of MSPharma
MSPharma has successfully raised a total of $45M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $45 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $45M
- Total Rounds 2
- Last Round Private Equity Round — $45M
- First Round $30M
(Mar 2015)
- Investors Count 2
All 2 funding rounds of MSPharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in MSPharma
MSPharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include International Finance Corporation and EBRD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate advisory services are provided across multiple sectors. | 1991 | ebrd.com | London, United Kingdom | |
IFC is focused on private sector development in emerging markets. | 1956 | ifc.org |
Investor details for MSPharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MSPharma
21 people are tracked at MSPharma (12 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Mohammad Katou | Injectable Operations Vice President | Leadership |
Hichem Messaoudi | Executive Vice President & Chief Information Officer | Leadership |
Samer Jalal | Executive Vice President People, Culture and Communication | Leadership |
Rawan Aldhrgham | Head Of KAM | Leadership |
Nimer Qarqash | Digital & IT - Vice President | Leadership |
Faten Dababneh | Head Of Corporate Finance | Leadership |
Adam Dimitropoulos Cpa | Group CFO | Leadership |
Nour Hirzallah | Business Development And PMO Director | Leadership |
Kalle Känd | CEO | Leadership |
Farah Irqsusi | Talent Management Director | Leadership |
Zaid Madanat | Country Director | Leadership |
Stefan Busemann | Executive Vice President Business Development | Leadership |
Sherif Ezz Eldin | Key Account Manager | Team |
Hadeel Abd al-Hadi | Medical Sales Representative | Team |
Maha Hasan Sphri™ | People & Culture Supervisor | Team |
Qais Abzakh | Corporate Financial Planning & Analysis Manager | Team |
Nadia Alhamad | Business Development & Regulatory Affairs Manager -consumer Health Care | Team |
Luqman Awla Hamza | Key Account Manager | Team |
Ahmad Jebarah | IT Manager | Team |
Alaa Ali | People & Culture Operations Manager | Team |
1 more people are available in the full profile.
Complete people profiles for MSPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MSPharma
MSPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genepharm.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Generic drugs are manufactured in Pallini, Greece. | genepharm.com | Pallini, Greece | 1967 | Apr 2019 | •••• |
Complete acquisition details for MSPharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of MSPharma
4 dated milestones of MSPharma across 30 years, from founding to its latest funding, stage changes and deals.
- Founded MSPharma is founded.
- Funding First funding round of $30.0M.
- Funding Latest funding round, Private Equity Round, of $45.0M.
- Acquisition Acquires Genepharm.
Web traffic of MSPharma
The website of MSPharma (mspharma.com) receives about 12.4K visits a month and ranks #1,443,733 among all websites worldwide, #1,874 in Biotechnology and Pharmaceuticals.
- Monthly visits12.4K
▼ 27.5% vs previous month
- Unique visitors7.7K
per month
- Global rank#1,443,733
among all websites
- Category rank#1,874
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit2.0
- Average visit29 sec
- DevicesDesktop 25% · Mobile 75%
Websites whose visitors overlap most with MSPharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dadgroup.com | 100% | 680.7K | #3,450,381 | View details | |
| sajapharma.com | 99% | #2,534,807 | View details | ||
| tabukpharmaceuticals.com | 95% | 28.7K | #1,212,851 | View details | |
| julphar.net | 94% | 10.8K | #898,528 | View details | |
jpm.com.jo | jpm.com.jo | 82% | #6,722,301 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for MSPharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mspharma
Complete news archive for MSPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSPharma
MSPharma was founded in 1989 and raised its 1st funding round 26 years after it was founded.
MSPharma is headquartered in Amman, Jordan.
MSPharma is a funded company, having raised a total of $45M across 2 funding rounds to date. The company's 1st funding round was a Debt – Venture of $30M, raised on Mar 2015.
MSPharma was founded in 1989 in Amman, Jordan, within the pharmaceutical sector. Generic formulations are produced for therapeutic areas such as cardiovascular, central nervous system, respiratory, infections, endocrine, obstetrics, gynecology, urinary tract, and musculoskeletal conditions. Over-the-counter products are also manufactured, including gastrointestinal treatments, medico-cosmetics, feminine healthcare, baby care, cold and cough remedies, pain relief, diagnostics, food supplements, nutraceuticals, and multivitamins. Operations focus on standard pharmaceutical manufacturing processes.
MSPharma offers Generic Medicines, Specialty Medicines, and Biotech Products.
MSPharma has made 1 acquisition, including Genepharm.
MSPharma has 2 investors. Key investors include International Finance Corporation, and EBRD.